(Q34938801)

English

Biomarkers and surrogate endpoints: how and when might they impact drug development?

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

5 August 2017

Biomarkers and surrogate endpoints: how and when might they impact drug development? (English)

1 reference

stated in

Europe PubMed Central

5 August 2017

0 references

Chetan D Lathia

1

1 reference

stated in

Europe PubMed Central

5 August 2017

1 January 2002

1 reference

stated in

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

18

1 reference

stated in

Europe PubMed Central

5 August 2017

2

1 reference

stated in

Europe PubMed Central

5 August 2017

83-90

1 reference

stated in

Europe PubMed Central

5 August 2017

Creative Commons Attribution 3.0 Unported

start time

1 January 2002

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

stated in

April 2022 Public Data File from Crossref

Identifiers

DOI

10.1155/2002/438745

1 reference

stated in

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

PubMed ID

12364814

retrieved

5 August 2017

ResearchGate publication ID

11093567

0 references

(Q34938801)

Biomarkers and surrogate endpoints: how and when might they impact drug development?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)